Considering the current global health pandemic known as COVID-19, the pharmaceutical industry has a real life scenario to test out the business continuity planning of the Pharmacovigilance (PV) operat

With the outbreak of the COVID-19 virus the European Medicines Agency (EMA) issued guidance on 20th March 2020 for conducting Clinical Trials during the Pandemic. While the guidance was primarily focu

Drug companies are continuously striving to reduce and streamline clinical drug development. However, with the current pandemic precautions, increasing pressures to reduce climate impact, political un